Abstract
Background
Implant infection continues to be the most common complication of breast reconstruction, and it can lead to serious consequences of implant loss. Recently, endoscopic-assisted nipple-sparing mastectomy with direct-to-implant breast reconstruction is being performed more frequently, with similar prosthetic infection incidence compared to conventional techniques. But there is little information published in the literature on the management of periprosthetic infection in endoscopic-assisted breast reconstruction.
Methods
A retrospective review was performed of patients who underwent endoscope-assisted breast reconstruction and developed periprosthetic infection between January 2020 and December 2022. Prosthesis infection was defined as any case where antibiotics were given, beyond the surgeon’s standard perioperative period, in response to clinical signs such as swelling, pain, erythema, increased temperature, fever, etc. We summarized our clinical approach and treatment protocol for periprosthetic infection patients. Collected data include preoperative basic information, surgical details, postoperative data, and outcomes.
Results
A total of 580 patients (713 reconstructions) underwent endoscopic-assisted immediate breast reconstruction. There were 58 patients developed periprosthetic infection, 14 of whom had bilateral prosthesis reconstruction with unilateral prosthesis infection. The incidence of infection was 10.0%. Average follow-up was 17.3 ± 8.9 months (range = 2–37 months). Of the 58 patients, 53 (91.4%) patients successful salvaged implant and 5(8.6%) patients removed prosthesis. During follow-up, Baker III capsular contracture occurred in 2 patients (3.8%) who had radiotherapy.
Conclusion
Our management of prosthesis infections in endoscopic-assisted breast reconstruction is easy, minimally invasive, and inexpensive. This method can be repeated if the implant infection does not improve after the first drainage. What’s more, our data suggest that our prosthesis salvage of periprosthetic infection is effective.
Level of Evidence IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
References
Pittet B, Montandon D, Pittet D (2005) Infection in breast implants. Lancet Infect Dis 5:94–106
Fischer JP, Wes AM, Nelson JA et al (2014) Propensity-matched, longitudinal outcomes analysis of complications and cost: comparing abdominal free flaps and implant-based breast reconstruction. J Am Coll Surg 219:303–312
McCarthy CM, Mehrara BJ, Riedel E et al (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121:1886–1892
Spear SL, Howard MA, Boehmler JH et al (2004) The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg 113:1634–1644
Spear SL, Seruya M (2010) Management of the infected or exposed breast prosthesis: a single surgeon’s 15-year experience with 69 patients. Plast Reconstr Surg 125:1074–1084
Armstrong RW, Berkowitz RL, Bolding F (1989) Infection following breast reconstruction. Ann Plast Surg 23:284–288
Chun JK, Schulman MR (2007) The infected breast prosthesis after mastectomy reconstruction: successful salvage of nine implants in eight consecutive patients. Plast Reconstr Surg 120:581–589
Cordeiro PG, McCarthy CM (2006) A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: part I. a prospective analysis of early complications. Plast Reconstr Surg 118:825–831
Disa JJ, Ad-El DD, Cohen SM et al (1999) The premature removal of tissue expanders in breast reconstruction. Plast Reconstr Surg 104:1662–1665
Handel N, Jensen JA, Black Q et al (1995) The fate of breast implants: a critical analysis of complications and outcomes. Plast Reconstr Surg 96:1521–1533
Spear SL, Majidian A (1998) Immediate breast reconstruction in two stages using textured, integrated-valve tissue expanders and breast implants: a retrospective review of 171 consecutive breast reconstructions from 1989 to 1996. Plast Reconstr Surg 101:53–63
Nahabedian MY, Tsangaris T, Momen B, Manson PN (2003) Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 112:467–476
Franchelli S, Pesce M, Baldelli I et al (2018) Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction. Int J Infect Dis 71:67–72
Bramhall RJ, Hernan I, Harris PA (2018) A single-centre, retrospective proof-of-concept review of salvage of infected or exposed implant breast reconstructions with explantation and one-stage free flap replacement. J Plast Reconstr Aesthet Surg 71:194–200
Prince MD, Suber JS, Aya-Ay ML et al (2012) Prosthesis salvage in breast reconstruction patients with periprosthetic infection and exposure. Plast Reconstr Surg 129:42–48
Marcasciano M, Kaciulyte J, Giuli RD et al (2022) “Just Pulse it!” Introduction of a conservative implant salvage protocol to manage infection in pre-pectoral breast reconstruction: case series and literature review. J Plast Reconstr Aesthet Surg 75:571–578
Yii NW, Khoo CT (2003) Salvage of infected expander prostheses in breast reconstruction. Plast Reconstr Surg 111:1087–1092
Sakamoto N, Fukuma E, Higa K et al (2009) Early results of an endoscopic nipple-sparing mastectomy for breast cancer. Ann Surg Oncol 16:3406–3413
Selber JC (2019) Robotic nipple-sparing mastectomy: the next step in the evolution of minimally invasive breast surgery. Ann Surg Oncol 26:10–11
Mok CW, Lai HW (2019) Endoscopic-assisted surgery in the management of breast cancer: 20 years review of trend, techniques and outcomes. Breast 46:144–156
Lai HW, Chen ST, Lin YJ et al (2021) Minimal access (endoscopic and robotic) breast surgery in the surgical treatment of early breast cancer-trend and clinical outcome from a single-surgeon experience over 10 years. Front Oncol 11:739144
Lee HY, Chang YW, Yu DY et al (2021) Comparison of single incision endoscopic nipple-sparing mastectomy and conventional nipple-sparing mastectomy for breast cancer based on initial experience. J Breast Cancer 24:196–205
Zhang S, Xie Y, Liang F et al (2022) Video-assisted transaxillary nipple-sparing mastectomy and immediate implant-based breast reconstruction: a novel and promising method. Aesthet Plast Surg 46:91–98
Qiu J, Wen N, Xie Y et al (2022) Novel technique for endoscopic-assisted nipple-sparing mastectomy and immediate breast reconstruction with endoscopic-assisted latissimus dorsi muscle flap harvest through a single axillary incision: a retrospective cohort study of comparing endoscopic and open surgery. Gland Surg 11:1383–1394
Zhou J, Liu X, Feng Y et al (2021) Breakthrough in breast reconstruction in the context of COVID-19: safety and efficiency of endoscopic breast reconstruction at a day surgery center. Gland Surg 10:2477–2489
Zhang S, Xie Y, Liang F et al (2021) Endoscopic-assisted nipple-sparing mastectomy with direct-to-implant subpectoral breast reconstruction in the management of breast cancer. Plast Reconstr Surg Glob Open 9:e3978
Wu X, Luo Y, Zeng Y et al (2020) Prospective comparison of indwelling cannulas drain and needle aspiration for symptomatic seroma after mastectomy in breast cancer patients. Arch Gynecol Obstet 301:283–287
Ozturk C, Ozturk CN, Platek M et al (2020) Management of expander and implant-associated infections in breast reconstruction. Aesthet Plast Surg 44:2075–2082
Feldman EM, Kontoyiannis DP, Sharabi SE et al (2010) Breast implant infections: is cefazolin enough? Plast Reconstr Surg 126:779–785
Reish RG, Damjanovic B, Austen WG Jr et al (2013) Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg 131:1223–1230
Franchelli S, Pesce M, Savaia S et al (2015) Clinical and microbiological characterization of late breast implant infections after reconstructive breast cancer surgery. Surg Infect (Larchmt) 16:636–644
Klein GM, Phillips BT, Dagum AB et al (2017) Infectious loss of tissue expanders in breast reconstruction: are we treating the right organisms? Ann Plast Surg 78:149–152
Author information
Authors and Affiliations
Contributions
(I) Conception and design: QL, BL, YX; (II) Administrative support: none; (III) Provision of study materials or patients: QL, YX, ZD; (IV) Collection and assembly of data: XH, ZD, FL; (V) Data analysis and interpretation: YX, XH; (VI) Manuscript writing: all authors; (VII) Final approval of manuscript: all authors.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors as it was a retrospective study.
Informed Consent
For this type of study, informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xie, Y., Hu, X., Du, Z. et al. Minimally Invasive and Innovative Management of Prosthesis Infections in Endoscopic-Assisted Breast Reconstruction. Aesth Plast Surg 48, 266–272 (2024). https://doi.org/10.1007/s00266-023-03525-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-023-03525-6